COVID-19

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 15, 2022.

Immunocompromised individuals are at higher risk of contracting COVID-19. But do the current treatments protect them? If not, then what needs to be done?

Association for Professionals in Infection Control and Epidemiology released a statement on how to protect against COVID-19, influenza, and RSV.

Saskia v. Popescu covers the news about COVID-19 cases, Ebola, and cholera in the week before Christmas, 2022.

With many of the new COVID-19 vaccines not as effective against the new variants, reducing their spread without pharmaceuticals is even more critical.

Kevin Kavanagh, MD, reviews a book examining the results of Sweden's controversial decisions made during the early COVID-19 pandemic.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 9, 2022.

Vaccines are one of the best weapons scientists have against pandemics. What can scientists and medical professionals do to prepare better vaccines for the next pandemic?

Ambulatory health care facilities deserve infection prevention and control resources with the preparedness to address the unique complexities of their health care setting.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 2, 2022

A summary of the top stories of 2022, and what to look for in the new year.

Integrating home and community, long-term care facilities are supposed to be a haven for patients and their families. But during the COVID-19 pandemic, keeping the patients and the staff safe was a constant battle. An infection preventionist who lived through it discusses the challenges at her facility.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 25, 2022.

Artificial intelligence increases infection prevention and control measures in health care facilities and beyond.

Now is the time to enjoy the holidays, but it is not time to forget to protect against RSV, COVID-19, and influenza.

As the festive holidays begin, even with vaccinations and boosters, COVID-19 still remains a concern for long COVID-19 and other severe long-term effects.

A student-led COVID-19 contact-tracer program reduced exposures and infections at start of the pandemic.

Hospitalized children may be scared and uncertain, and therapy animals can help ease their insecurities. But what is done to protect the humans—and the animals—from infectious diseases?

Saskia v. Popescu, PhD, MPH, MA, CIC, covers updates on health care associated-infections, masking at schools, and Ebola in Uganda and Dengue in Arizona. Read on for all the details.

No new safety concerns with this COVID-19 vaccine were reported.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 11, 2022.

Infection prevention and control personnel don't elect to ever stop. Dr. Popescu tells us what's in the news this week of the mid-term elections.

Extra-intestinal pathogenic Escherichia coli (ExPEC) and Staphylococcus aureus (S. aureus) are 2 of the leading causes of severe sepsis, and Janssen Pharmaceutical Companies of Johnson & Johnson is developing vaccines to fight those diseases.

Association for Professionals in Infection Control and Epidemiology’s (APIC’s) CDS Conference is virtual this year, and the topics are environmental hygiene and sterile processing.

CDC discusses potential proposals to redefine spread and to produce uniform guidelines across different types of facilities because public health interventions do not cause immunological debt but instead may prevent immunocompromising infections.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 4, 2022.

What is scary in infection prevention and control? Dr. Popescu tells us what's in the news this week of Halloween.

Infection prevention in pediatrics is crucial to keep babies and children healthy. Some of the main tools are hand washing and vaccinations; however, there is more to do.

Despite study results that the univalent BA.5 booster produced much higher increase in antibodies, why was the hybrid bivalent Ancestral/BA.5 booster with a significantly lower increase chosen to be distributed, and how does this put the population at risk?

Can antimicrobial products withstand day-to-day real-life wear and tear if the antimicrobial material is part of the product and not only a coating? A study in Switzerland tried to find out.